A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women
Titel:
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women
Auteur:
Cigler, T. Richardson, H. Yaffe, M. J. Fabian, C. J. Johnston, D. Ingle, J. N. Nassif, E. Brunner, R. L. Wood, M. E. Pater, J. L. Hu, H. Qi, S. Tu, D. Goss, P. E.